231 related articles for article (PubMed ID: 2736512)
1. Poorly metastatic tumor cell variants as primary targets of syngeneic antibody responses against murine melanoma.
Parratto NP; Odebralski JM; Kimura AK
Cancer Res; 1989 Jul; 49(14):3722-8. PubMed ID: 2736512
[TBL] [Abstract][Full Text] [Related]
2. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; BĂ©rard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
3. High levels of Met-72 antigen expression: correlation with metastatic activity of B16 melanoma tumor cell variants.
Kimura AK; Xiang JH
J Natl Cancer Inst; 1986 Jun; 76(6):1247-54. PubMed ID: 3486997
[TBL] [Abstract][Full Text] [Related]
4. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A
Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921
[TBL] [Abstract][Full Text] [Related]
5. Differences in cytotoxic effects of activated murine peritoneal macrophages and J774 monocytic cells on metastatic variants of B16 melanoma.
Miner KM; Klostergaard J; Granger GA; Nicolson GL
J Natl Cancer Inst; 1983 Apr; 70(4):717-24. PubMed ID: 6339778
[TBL] [Abstract][Full Text] [Related]
6. Syngeneic monoclonal antibodies to B16 melanoma viral antigens.
Rappaport I; Alterman AL; Braverman S; Stackpole CW
Cancer Res; 1987 Oct; 47(20):5391-6. PubMed ID: 3652042
[TBL] [Abstract][Full Text] [Related]
7. Multiple antigens related to the major envelope glycoprotein of murine leukemia virus expressed on B16 melanoma cells as targets of host immune response.
Stackpole CW; Demsey A
Invasion Metastasis; 1984; 4(1):28-46. PubMed ID: 6329988
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic transfer of metastatic activity by uptake of highly metastatic B16 melanoma cell-released exosomes.
Hao S; Ye Z; Li F; Meng Q; Qureshi M; Yang J; Xiang J
Exp Oncol; 2006 Jun; 28(2):126-31. PubMed ID: 16837903
[TBL] [Abstract][Full Text] [Related]
9. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials.
LeGrue SJ; Hearn DR
Cancer Res; 1983 Nov; 43(11):5106-11. PubMed ID: 6616449
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors, and individual lung metastases.
Poste G; Doll J; Brown AE; Tzeng J; Zeidman I
Cancer Res; 1982 Jul; 42(7):2770-8. PubMed ID: 7083167
[TBL] [Abstract][Full Text] [Related]
11. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
Pan JP; Weng YS; Wu QQ
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
[TBL] [Abstract][Full Text] [Related]
12. Isolation and visualization of Met-72-positive, metastatic variants present in B16 melanoma tumor masses.
Parratto NP; Kimura AK
J Cell Biochem; 1988 Mar; 36(3):311-22. PubMed ID: 3379105
[TBL] [Abstract][Full Text] [Related]
13. [Immunogenicity of 2 murine B16 melanoma variants with high metastatic potential].
Hosni M; Santini R; Deschaux P; Pacheco H
C R Seances Soc Biol Fil; 1990; 184(1):47-54. PubMed ID: 2150781
[TBL] [Abstract][Full Text] [Related]
14. The role of intratumor environment in determining spontaneous metastatic activity of a B16 melanoma clone.
Alterman AL; Fornabaio DM; Kim YS; Stackpole CW
Invasion Metastasis; 1989; 9(4):242-53. PubMed ID: 2737843
[TBL] [Abstract][Full Text] [Related]
15. The relationship between motility factor receptor internalization and the lung colonization capacity of murine melanoma cells.
Watanabe H; Nabi IR; Raz A
Cancer Res; 1991 May; 51(10):2699-705. PubMed ID: 2021948
[TBL] [Abstract][Full Text] [Related]
16. Suppression of B16 melanoma lung colonization by syngeneic monoclonal antibodies.
Herd ZL
Cancer Res; 1987 May; 47(10):2696-703. PubMed ID: 3552203
[TBL] [Abstract][Full Text] [Related]
17. Phorbol 12-myristate 13-acetate enhances nm23 gene expression in murine melanocytes but not in syngeneic B16-BL6 melanoma variants.
Huijzer JC; McFarland M; Niles RM; Meadows GG
J Cell Physiol; 1996 Mar; 166(3):487-94. PubMed ID: 8600152
[TBL] [Abstract][Full Text] [Related]
18. Modulation of metastatic potential by cell surface urokinase of murine melanoma cells.
Hearing VJ; Law LW; Corti A; Appella E; Blasi F
Cancer Res; 1988 Mar; 48(5):1270-8. PubMed ID: 2963689
[TBL] [Abstract][Full Text] [Related]
19. [The mechanism of anti-tumor immune response against mouse melanoma to xenogeneic vaccination].
Luo F; Mao YQ; Kan B; He QM; Jiang Y; Peng F; Yang L; Tian L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):757-60. PubMed ID: 15573746
[TBL] [Abstract][Full Text] [Related]
20. Generation of phenotypic diversity in the B16 mouse melanoma relative to spontaneous metastasis.
Stackpole CW
Cancer Res; 1983 Jul; 43(7):3057-65. PubMed ID: 6850615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]